Equities analysts expect Agiliti, Inc. (NYSE:AGTI – Get Rating) to post $292.94 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Agiliti’s earnings, with the lowest sales estimate coming in at $291.30 million and the highest estimate coming in at $294.40 million. Agiliti posted sales of $235.25 million during the same quarter last year, which suggests a positive year over year growth rate of 24.5%. The firm is scheduled to announce its next earnings report after the market closes on Monday, January 1st.
On average, analysts expect that Agiliti will report full year sales of $1.18 billion for the current year, with estimates ranging from $1.17 billion to $1.19 billion. For the next fiscal year, analysts forecast that the firm will report sales of $1.28 billion, with estimates ranging from $1.26 billion to $1.29 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that follow Agiliti.
Agiliti (NYSE:AGTI – Get Rating) last issued its quarterly earnings results on Tuesday, March 8th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.16. Agiliti had a net margin of 2.31% and a return on equity of 15.02%.
Shares of NYSE:AGTI opened at $20.16 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.72 and a quick ratio of 1.45. Agiliti has a 1-year low of $13.56 and a 1-year high of $26.36. The company has a market capitalization of $2.64 billion and a P/E ratio of 106.11. The firm’s 50 day simple moving average is $19.66 and its two-hundred day simple moving average is $20.59.
In other Agiliti news, CEO Thomas J. Leonard sold 30,000 shares of the business’s stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $18.04, for a total transaction of $541,200.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Lee M. Neumann sold 10,043 shares of the business’s stock in a transaction on Monday, April 18th. The shares were sold at an average price of $21.84, for a total transaction of $219,339.12. Following the transaction, the executive vice president now owns 63,197 shares in the company, valued at approximately $1,380,222.48. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 145,127 shares of company stock worth $2,634,379. 4.16% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its holdings in shares of Agiliti by 4.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,048,176 shares of the company’s stock worth $38,997,000 after purchasing an additional 84,279 shares during the last quarter. Sectoral Asset Management Inc grew its holdings in shares of Agiliti by 18.0% in the third quarter. Sectoral Asset Management Inc now owns 977,269 shares of the company’s stock worth $18,607,000 after purchasing an additional 148,900 shares during the last quarter. Strs Ohio grew its holdings in shares of Agiliti by 88.5% in the third quarter. Strs Ohio now owns 9,800 shares of the company’s stock worth $186,000 after purchasing an additional 4,600 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Agiliti in the third quarter worth about $501,000. Finally, BlackRock Inc. grew its holdings in shares of Agiliti by 5.3% in the third quarter. BlackRock Inc. now owns 2,998,163 shares of the company’s stock worth $57,086,000 after purchasing an additional 149,986 shares during the last quarter. Hedge funds and other institutional investors own 99.81% of the company’s stock.
About Agiliti (Get Rating)
Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.
- Get a free copy of the StockNews.com research report on Agiliti (AGTI)
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
- Tractor Supply Company Reaps What It Sows
- Snap (NYSE: SNAP) Gives Investors A Mixed Bag
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.